IP Verse

Combination - EP2488033B1

PatentPatent Analysis

EP2488033

GLAXOSMITHKLINE
Application Number
EP10824148A
Filing Date
Oct 15, 2010
Status
Opposition Rejected
Mar 11, 2022
Grant Date
Jun 12, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4226941B1
EP3682884B1
EP3480209B1

Bibliography

The patent EP2488033B1 was granted to Glaxosmithkline on Jun 12, 2019 following the initial filing on Oct 15, 2010 under the application number EP10824148A . The current legal status of the patent is Opposition Rejected.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKMar 12, 2020ADMISSIBLE
TEVA PHARMACEUTICALSMar 12, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents